CN108659814B - Quaternary water-soluble quantum dot and preparation method and application thereof - Google Patents
Quaternary water-soluble quantum dot and preparation method and application thereof Download PDFInfo
- Publication number
- CN108659814B CN108659814B CN201810023802.2A CN201810023802A CN108659814B CN 108659814 B CN108659814 B CN 108659814B CN 201810023802 A CN201810023802 A CN 201810023802A CN 108659814 B CN108659814 B CN 108659814B
- Authority
- CN
- China
- Prior art keywords
- aqueous solution
- indium
- gallium
- salt
- solution containing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K11/00—Luminescent, e.g. electroluminescent, chemiluminescent materials
- C09K11/02—Use of particular materials as binders, particle coatings or suspension media therefor
- C09K11/025—Use of particular materials as binders, particle coatings or suspension media therefor non-luminescent particle coatings or suspension media
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y20/00—Nanooptics, e.g. quantum optics or photonic crystals
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y30/00—Nanotechnology for materials or surface science, e.g. nanocomposites
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y40/00—Manufacture or treatment of nanostructures
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K11/00—Luminescent, e.g. electroluminescent, chemiluminescent materials
- C09K11/08—Luminescent, e.g. electroluminescent, chemiluminescent materials containing inorganic luminescent materials
- C09K11/62—Luminescent, e.g. electroluminescent, chemiluminescent materials containing inorganic luminescent materials containing gallium, indium or thallium
- C09K11/621—Chalcogenides
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/6486—Measuring fluorescence of biological material, e.g. DNA, RNA, cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N2021/6497—Miscellaneous applications
Landscapes
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nanotechnology (AREA)
- Physics & Mathematics (AREA)
- General Physics & Mathematics (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Crystallography & Structural Chemistry (AREA)
- Materials Engineering (AREA)
- Organic Chemistry (AREA)
- Condensed Matter Physics & Semiconductors (AREA)
- Composite Materials (AREA)
- Biomedical Technology (AREA)
- Pathology (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Analytical Chemistry (AREA)
- Immunology (AREA)
- Inorganic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biophysics (AREA)
- Optics & Photonics (AREA)
- Manufacturing & Machinery (AREA)
- Luminescent Compositions (AREA)
- Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
Abstract
Description
技术领域technical field
本发明涉及量子点材料领域,具体涉及一种四元水溶性量子点及其制备方法和应用。The invention relates to the field of quantum dot materials, in particular to a quaternary water-soluble quantum dot and a preparation method and application thereof.
背景技术Background technique
半导体纳米晶(Nanocrystals,NCs),也被称之为量子点(Quantum dots,QDs),是一种在空间三个维度上都受到限制的半导体材料;量子点研究至今,出现了多种类型结构和材料;从结构划分,有核壳结构、合金结构、异质结构等;从材料种类而言,有II-VI族(如CdS)、III-V族(如InP)等;这些种类的量子点研制历程较久,因此合成工艺很成熟,但是含有A类重金属元素,如Cd、Hg等,因此对生物环境产生了巨大的损害。Semiconductor nanocrystals (NCs), also known as quantum dots (QDs), are semiconductor materials that are restricted in all three dimensions of space; quantum dots have been studied so far, and various types of structures have appeared. and materials; in terms of structure, there are core-shell structures, alloy structures, heterostructures, etc.; in terms of material types, there are II-VI groups (such as CdS), III-V groups (such as InP), etc.; these kinds of quantum It has a long development process, so the synthesis process is very mature, but it contains A-type heavy metal elements, such as Cd, Hg, etc., so it has caused huge damage to the biological environment.
从2007年成功合成了AgInS2量子点开始,由此开启了I-III-V族三元量子点的研究;三元量子点具有较高的光吸收系数、较好的生物相容性和较强的缺陷耐受性,因此得到了人们的关注;然而目前合成的三元I-III-V族量子点大都是有机合成,而且量子产率普遍较低,极大限制了它们在发光材料和生物标记领域的应用。Since the successful synthesis of AgInS 2 quantum dots in 2007, the research on I-III-V ternary quantum dots has been started; ternary quantum dots have high light absorption coefficient, good biocompatibility and However, most of the currently synthesized ternary I-III-V quantum dots are organically synthesized, and the quantum yield is generally low, which greatly limits their use in luminescent materials and luminescent materials. Applications in the field of biomarkers.
发明内容SUMMARY OF THE INVENTION
有鉴于此,本发明的主要目的在于提供一种四元水溶性量子点,解决了现有技术中量子点的量子产率低以及生物相容性不佳的问题。In view of this, the main purpose of the present invention is to provide a quaternary water-soluble quantum dot, which solves the problems of low quantum yield and poor biocompatibility of quantum dots in the prior art.
为达到上述目的,本发明的技术方案是这样实现的:一种四元水溶性量子点,其包括AgGaInS的核和包覆在AgGaInS的核表面上的包覆剂。In order to achieve the above object, the technical solution of the present invention is realized as follows: a quaternary water-soluble quantum dot, which includes a core of AgGaInS and a coating agent coated on the surface of the core of AgGaInS.
优选地,所述包覆剂由谷胱甘肽类似物和柠檬酸钠组成。Preferably, the coating consists of glutathione analog and sodium citrate.
本发明的另一个技术方案是这样实现的:一种四元水溶性量子点的制备方法,该方法通过如下步骤实现:Another technical scheme of the present invention is realized in this way: a preparation method of quaternary water-soluble quantum dots, the method is realized by the following steps:
步骤1,向含有银盐、铟盐、镓盐的混合水溶液中加入含有包覆剂的水溶液并搅拌均匀,获得前驱体溶液;Step 1, adding an aqueous solution containing a coating agent to the mixed aqueous solution containing silver salt, indium salt and gallium salt and stirring uniformly to obtain a precursor solution;
步骤2,调节所述步骤1获得的前驱体溶液的pH值至8~10.5,获得碱性前驱体溶液;
步骤3,向所述步骤2获得的碱性前驱体溶液中加入含有硫源的水溶液搅拌均匀,获得含有碱性前驱体与硫源的混合水溶液;Step 3, adding an aqueous solution containing a sulfur source to the alkaline precursor solution obtained in the
步骤4,对所述步骤3获得的含有碱性前驱体与硫源的混合水溶液进行分步水热法处理,获得四元水溶性量子点(表面包覆剂包覆的AgGaInS量子点)。Step 4, performing step-by-step hydrothermal treatment on the mixed aqueous solution containing the alkaline precursor and the sulfur source obtained in the step 3 to obtain quaternary water-soluble quantum dots (AgGaInS quantum dots coated with a surface coating agent).
优选地,所述步骤1中,所述含有银盐、铟盐、镓盐的混合水溶液中铟离子、镓离子的摩尔量之和与银离子的摩尔量之比为1:(0.05~1);所述含有银盐、铟盐、镓盐的混合水溶液中铟离子、镓离子、银离子的摩尔量之和与含有包覆剂的水溶液中的包覆剂的摩尔量之比为1:(6~15)。Preferably, in the step 1, the ratio of the molar amount of indium ions and gallium ions to the molar amount of silver ions in the mixed aqueous solution containing silver salt, indium salt and gallium salt is 1:(0.05~1) ; The ratio of the molar amount of indium ion, gallium ion, silver ion in the mixed aqueous solution containing silver salt, indium salt, gallium salt and the molar amount of the coating agent in the aqueous solution containing the coating agent is 1: ( 6 to 15).
优选地,所述步骤1中,所述含有银盐、铟盐、镓盐的混合水溶液中银离子的物质的量浓度为0.01~0.15mol/L,铟离子的物质的量浓度为0.01~0.15mol/L,镓离子的物质的量浓度为0.01~0.15mol/L;所述含有包覆剂水溶液中包覆剂的物质的量浓度为0.01~0.6mol/L。Preferably, in the step 1, the amount concentration of silver ions in the mixed aqueous solution containing silver salt, indium salt and gallium salt is 0.01-0.15mol/L, and the amount concentration of indium ions is 0.01-0.15mol /L, the substance concentration of gallium ions is 0.01-0.15 mol/L; the substance concentration of the coating agent in the aqueous solution containing the coating agent is 0.01-0.6 mol/L.
优选地,所述步骤1中,所述银盐为硝酸银、乙酸银中的至少一种;所述铟盐为硝酸铟、乙酸铟、氯化铟中的至少一种;所述镓盐为硝酸镓、硫酸镓、氯化镓中的至少一种。Preferably, in the step 1, the silver salt is at least one of silver nitrate and silver acetate; the indium salt is at least one of indium nitrate, indium acetate and indium chloride; the gallium salt is At least one of gallium nitrate, gallium sulfate, and gallium chloride.
优选地,所述步骤3中,所述碱性前驱体中铟离子、镓离子、银离子的摩尔量之和与含有硫源水溶液中硫元素的摩尔量之比为1:(1~20);所述硫源水溶液中硫元素的物质的量浓度为0.01~0.15mol/L;所述硫源为硫代乙酰胺、硫脲、硫化钠中的至少一种。Preferably, in the step 3, the ratio of the sum of the molar amounts of indium ions, gallium ions and silver ions in the alkaline precursor to the molar amount of sulfur in the aqueous solution containing the sulfur source is 1: (1-20) The amount concentration of sulfur element in the sulfur source aqueous solution is 0.01-0.15 mol/L; the sulfur source is at least one of thioacetamide, thiourea and sodium sulfide.
优选地,所述步骤4中具体方法为:将所述含有碱性前驱体与硫源的混合水溶液加热到60~80℃,恒温30~50min,再加热到110~120℃,恒温120~240min,冷却、离心分离,获得四元水溶性量子点。Preferably, the specific method in the step 4 is: heating the mixed aqueous solution containing the alkaline precursor and the sulfur source to 60-80°C, at a constant temperature of 30-50min, and then heating it to 110-120°C at a constant temperature of 120-240min , cooling and centrifugal separation to obtain quaternary water-soluble quantum dots.
本发明四元水溶性量子点多作为荧光探针的用途;该荧光探针主要用于光电、生物和医学领域。The quaternary water-soluble quantum dots of the invention are mostly used as fluorescent probes; the fluorescent probes are mainly used in the fields of optoelectronics, biology and medicine.
与现有技术相比,本发明通过采用分步水热法获得的量子点的结晶性非常高,尺寸分布非常均一,荧光峰可调范围广且介于450~750nm,荧光量子产率高达25%以上;此外,本发明通过选用含有生物活性大分子的寡肽作为表面包覆剂,能够很好地应用于光电器件和生物标记中。Compared with the prior art, the quantum dots obtained by adopting the step-by-step hydrothermal method have very high crystallinity, very uniform size distribution, a wide adjustable range of fluorescence peaks ranging from 450 to 750 nm, and the fluorescence quantum yield is as high as 25. % or more; in addition, the present invention can be well applied to optoelectronic devices and biological markers by selecting oligopeptides containing biologically active macromolecules as surface coating agents.
附图说明Description of drawings
图1为本发明实施例提供的四元水溶性量子点的合成示意图;Fig. 1 is the synthetic schematic diagram of quaternary water-soluble quantum dots provided in the embodiment of the present invention;
图2为本发明实施例提供的四元水溶性量子点的高分辨透射电镜图;2 is a high-resolution transmission electron microscope image of quaternary water-soluble quantum dots provided in an embodiment of the present invention;
图3为本发明实施例提供的四元水溶性量子点的荧光光谱图;Fig. 3 is the fluorescence spectrogram of the quaternary water-soluble quantum dot provided in the embodiment of the present invention;
图4为本发明实施例提供的四元水溶性量子点的荧光量子产率示意图;4 is a schematic diagram of the fluorescence quantum yield of the quaternary water-soluble quantum dots provided in the embodiment of the present invention;
图5为本发明实施例提供的四元水溶性量子点进行细胞毒性检测结果示意图。FIG. 5 is a schematic diagram of the cytotoxicity detection results of the quaternary water-soluble quantum dots provided in the embodiment of the present invention.
具体实施方式Detailed ways
为了使本发明的目的、技术方案及优点更加清楚明白,以下结合附图及实施例,对本发明进行进一步详细说明。应当理解,此处所描述的具体实施例仅仅用以解释本发明,并不用于限定本发明。In order to make the objectives, technical solutions and advantages of the present invention clearer, the present invention will be further described in detail below with reference to the accompanying drawings and embodiments. It should be understood that the specific embodiments described herein are only used to explain the present invention, but not to limit the present invention.
在本发明中采用的符号和式子有本领域公知的含义。具体地,AgGaInS表示由银、铟、镓和硫元素组成的合金;Glu-Cys-Pro寡肽为即谷氨酸-半胱氨酸-脯氨酸三肽;包覆在量子点表面上的Glu-Cys-Pro寡肽是对表面修饰的生物相容性配体,其与表面上的金属离子配合。应当理解的是,虽然本文中将它们称为表面包覆剂,但并不意在限制它们在本发明的方法中仅起到表面包覆的作用。The symbols and formulae used in the present invention have the meanings known in the art. Specifically, AgGaInS represents an alloy composed of silver, indium, gallium and sulfur elements; Glu-Cys-Pro oligopeptide is glutamic acid-cysteine-proline tripeptide; coated on the surface of quantum dots Glu-Cys-Pro oligopeptides are surface-modified biocompatible ligands that complex with metal ions on the surface. It should be understood that although they are referred to herein as surface coating agents, they are not intended to limit their role as surface coating only in the method of the present invention.
本发明提供了实施例提供了一种四元水溶性量子点,其包括AgGaInS的核和包覆在表面上的包覆剂;其中,表面包覆剂由谷胱甘肽类似物和柠檬酸钠组成,谷胱甘肽类似物为Glu-Cys-Pro寡肽。The present invention provides an embodiment to provide a quaternary water-soluble quantum dot, which includes a core of AgGaInS and a coating agent coated on the surface; wherein, the surface coating agent is composed of glutathione analog and sodium citrate Compositionally, the glutathione analog is a Glu-Cys-Pro oligopeptide.
本发明还提供了一种四元水溶性量子点的制备方法,该方法通过如下步骤实现:The present invention also provides a preparation method of quaternary water-soluble quantum dots, which is realized by the following steps:
步骤1,向含有银盐、铟盐、镓盐的混合水溶液中加入含有物质的量浓度为0.01~0.6mol/L的包覆剂的水溶液并搅拌均匀,获得前驱体溶液;Step 1, adding an aqueous solution containing a coating agent with a substance concentration of 0.01 to 0.6 mol/L into the mixed aqueous solution containing silver salt, indium salt and gallium salt and stirring uniformly to obtain a precursor solution;
其中,含有银盐、铟盐、镓盐的混合水溶液中铟离子、镓离子的摩尔量之和与银离子的摩尔量之比为1:(0.05~1);含有银盐、铟盐、镓盐的混合水溶液中铟离子、镓离子、银离子的摩尔量之和与含有包覆剂的水溶液中的包覆剂的摩尔量之比为1:(6~15);含有银盐、铟盐、镓盐的混合水溶液中银离子的物质的量浓度为0.01~0.15mol/L,铟离子的物质的量浓度为0.01~0.15mol/L,镓离子的物质的量浓度为0.01~0.15mol/L;含有包覆剂水溶液中包覆剂的物质的量浓度为0.01~0.6mol/L;银盐为硝酸银、乙酸银中的至少一种;铟盐为硝酸铟、乙酸铟、氯化铟中的至少一种;镓盐为硝酸镓、硫酸镓、氯化镓中的至少一种。Among them, the ratio of the molar amount of indium ion and gallium ion in the mixed aqueous solution containing silver salt, indium salt and gallium salt to the molar amount of silver ion is 1:(0.05~1); The ratio of the sum of the molar amounts of indium ions, gallium ions and silver ions in the mixed aqueous solution of the salt to the molar amount of the coating agent in the aqueous solution containing the coating agent is 1: (6-15); containing silver salt, indium salt The substance concentration of silver ions in the mixed aqueous solution of gallium salt is 0.01~0.15mol/L, the substance concentration of indium ions is 0.01~0.15mol/L, and the substance concentration of gallium ions is 0.01~0.15mol/L The amount concentration of the substance containing the coating agent in the coating agent aqueous solution is 0.01 to 0.6 mol/L; the silver salt is at least one of silver nitrate and silver acetate; the indium salt is indium nitrate, indium acetate and indium chloride. At least one of gallium salt is at least one of gallium nitrate, gallium sulfate and gallium chloride.
步骤2,向步骤1获得的前驱体溶液中加入氢氧化钠溶液调节pH值至8~10.5,获得碱性前驱体溶液;
步骤3,向所述步骤2获得的碱性前驱体溶液中加入含有浓度为0.01~0.15mol/L的硫源的水溶液搅拌均匀,获得含有碱性前驱体与硫源的混合水溶液;其中,碱性前驱体中铟离子、镓离子、银离子的摩尔量之和与含有硫源溶液中硫元素的摩尔量之比为1:(1~20);含有硫源溶液中硫元素的物质的量浓度为0.01~0.15mol/L;硫源为硫代乙酰胺、硫脲、硫化钠中的至少一种。Step 3, adding an aqueous solution containing a sulfur source with a concentration of 0.01 to 0.15 mol/L to the alkaline precursor solution obtained in
步骤4,对所述步骤3获得的含有碱性前驱体与硫源的混合水溶液进行分步水热法处理,获得四元水溶性量子点(表面包覆剂包覆的AgGaInS量子点);其中,该步骤的具体方法为:将碱性前驱体与硫源的混合水溶液加热到60~80℃,恒温30~50min,再加热到110~120℃,恒温120~240min,冷却、离心分离,获得四元水溶性量子点(表面包覆剂包覆的AgGaInS量子点)。Step 4, performing step-by-step hydrothermal treatment on the mixed aqueous solution containing the alkaline precursor and the sulfur source obtained in the step 3 to obtain quaternary water-soluble quantum dots (AgGaInS quantum dots coated with a surface coating agent); wherein The specific method of this step is as follows: heating the mixed aqueous solution of the alkaline precursor and the sulfur source to 60-80°C, at a constant temperature of 30-50min, then heating it to 110-120°C, at a constant temperature of 120-240min, cooling and centrifuging to obtain Quaternary water-soluble quantum dots (AgGaInS quantum dots coated with surface coating agent).
本发明实施例获得的四元水溶性量子点多作为荧光探针的用途;该荧光探针主要用于光电、生物和医学领域。The quaternary water-soluble quantum dots obtained in the embodiment of the present invention are mostly used as fluorescent probes; the fluorescent probes are mainly used in the fields of optoelectronics, biology and medicine.
本发明通过采用分步水热法获得的量子点与现有一步水热法获得的量子点相比,本发明获得的量子点的结晶性非常高,尺寸分布非常均一,荧光峰可调范围广且介于450~750nm,荧光量子产率高达25%以上;此外,本发明通过选用含有生物活性大分子的寡肽作为表面包覆剂,能够很好地应用于光电器件和生物标记中。Compared with the quantum dots obtained by the existing one-step hydrothermal method, the quantum dots obtained by the present invention have very high crystallinity, a very uniform size distribution, and a wide adjustable range of fluorescence peaks. And between 450-750 nm, the fluorescence quantum yield is as high as more than 25%; in addition, the present invention can be well applied to optoelectronic devices and biological markers by selecting oligopeptides containing biologically active macromolecules as surface coating agents.
实施例1Example 1
一种四元水溶性量子点的制备方法,该方法通过如下步骤实现:A preparation method of quaternary water-soluble quantum dots, the method is realized by the following steps:
步骤1,分别将5ml 0.02mol/L的硝酸银水溶液、1mL 0.05mol/L的、硝酸铟水溶液、6mL 0.02mol/L的硝酸镓水溶液混合搅拌均匀,再加入1.5mL0.2mol/L的Glu-Cys-Pro寡肽水溶液和4.5mL 0.1mol/L的柠檬酸钠水溶液混合形成的包覆剂水溶液并搅拌均匀,获得前驱体溶液;Step 1, respectively mix and stir 5ml 0.02mol/L silver nitrate aqueous solution, 1mL 0.05mol/L indium nitrate aqueous solution, and 6mL 0.02mol/L gallium nitrate aqueous solution, and then add 1.5mL 0.2mol/L Glu- Cys-Pro oligopeptide aqueous solution and 4.5mL 0.1mol/L sodium citrate aqueous solution are mixed to form a coating agent aqueous solution and stirred evenly to obtain a precursor solution;
步骤2,向所述步骤1获得的前驱体溶液中加入氢氧化钠调节pH值至9,获得碱性前驱体溶液;
步骤3,向所述步骤2获得的碱性前驱体溶液中加入7.5mL 0.1mol/L的硫代乙酰胺的水溶液搅拌均匀,获得含有碱性前驱体与硫代乙酰胺的混合水溶液;Step 3, adding 7.5 mL of an aqueous solution of 0.1 mol/L thioacetamide to the alkaline precursor solution obtained in
步骤4,将步骤3获得的含有碱性前驱体与硫代乙酰胺的混合水溶液转移置高压釜中加热至60℃并恒温30min,再加热至110℃并恒温120min,冷却,再用过量的乙醇离心,获得沉淀,该沉淀为四元水溶性量子点(即:表面包覆剂包覆的AgInGaS量子点)。Step 4, transfer the mixed aqueous solution containing the alkaline precursor and thioacetamide obtained in step 3 into an autoclave, heat to 60 ° C and keep constant temperature for 30 min, then heat to 110 ° C and keep constant temperature for 120 min, cool, and then use excess ethanol Centrifuge to obtain a precipitate, which is a quaternary water-soluble quantum dot (ie, AgInGaS quantum dot coated with a surface coating agent).
实施例2Example 2
一种四元水溶性量子点的制备方法,该方法通过如下步骤实现:A preparation method of quaternary water-soluble quantum dots, the method is realized by the following steps:
步骤1,分别将5ml 0.02mol/L的硝酸银水溶液、1mL 0.05mol/L的、硝酸铟水溶液、6mL 0.02mol/L的硫酸镓水溶液混合搅拌均匀,再加入1.5mL0.2mol/L的Glu-Cys-Pro寡肽水溶液和4.5mL 0.1mol/L的柠檬酸钠水溶液混合形成的包覆剂水溶液并搅拌均匀,获得前驱体溶液;Step 1, respectively mix and stir 5ml 0.02mol/L silver nitrate aqueous solution, 1mL 0.05mol/L indium nitrate aqueous solution, and 6mL 0.02mol/L gallium sulfate aqueous solution, and then add 1.5mL 0.2mol/L Glu- Cys-Pro oligopeptide aqueous solution and 4.5mL 0.1mol/L sodium citrate aqueous solution are mixed to form a coating agent aqueous solution and stirred evenly to obtain a precursor solution;
步骤2,向所述步骤1获得的前驱体溶液中加入浓度为1mol/mL的氢氧化钠调节pH值至9,获得碱性前驱体溶液;
步骤3,向所述步骤2获得的碱性前驱体溶液中加入15mL 0.05mol/L的硫脲的水溶液搅拌均匀,获得含有碱性前驱体与硫脲的混合水溶液;Step 3, adding 15 mL of an aqueous solution of 0.05 mol/L thiourea to the alkaline precursor solution obtained in
步骤4,将步骤3获得的含有碱性前驱体与硫脲的混合水溶液转移置高压釜中加热至60℃并恒温30min,再加热至110℃并恒温130min,冷却,再用过量的乙醇离心,获得沉淀,该沉淀为四元水溶性量子点(即:表面包覆剂包覆的AgInGaS量子点)。In step 4, the mixed aqueous solution containing the alkaline precursor and thiourea obtained in step 3 is transferred into an autoclave, heated to 60 ° C and kept at a constant temperature for 30 min, then heated to 110 ° C and kept at a constant temperature for 130 min, cooled, and then centrifuged with excess ethanol, A precipitate was obtained, which was a quaternary water-soluble quantum dot (ie, AgInGaS quantum dot coated with a surface capping agent).
实施例3Example 3
一种四元水溶性量子点的制备方法,该方法通过如下步骤实现:A preparation method of quaternary water-soluble quantum dots, the method is realized by the following steps:
步骤1,分别将5ml 0.02mol/L的硝酸银水溶液、1.2mL 0.05mol/L的、硝酸铟水溶液、7.5mL 0.02mol/L的硝酸镓水溶液混合搅拌均匀,再加入8mL0.05mol/L的Glu-Cys-Pro寡肽水溶液和2.65mL 0.2mol/L的柠檬酸钠水溶液混合形成的包覆剂水溶液并搅拌均匀,获得前驱体溶液;Step 1, respectively mix and stir 5ml 0.02mol/L silver nitrate aqueous solution, 1.2mL 0.05mol/L, indium nitrate aqueous solution, and 7.5mL 0.02mol/L gallium nitrate aqueous solution, and then add 8mL 0.05mol/L Glu -The coating agent aqueous solution formed by mixing the Cys-Pro oligopeptide aqueous solution and the 2.65 mL 0.2 mol/L sodium citrate aqueous solution and stirring evenly to obtain the precursor solution;
步骤2,向所述步骤1获得的前驱体溶液中加入浓度为1mol/mL的氢氧化钠调节pH值至9,获得碱性前驱体溶液;
步骤3,向所述步骤2获得的碱性前驱体溶液中加入10.33mL 0.09mol/L的硫化钠的水溶液搅拌均匀,获得含有碱性前驱体与硫化钠的混合水溶液;Step 3, adding 10.33 mL of an aqueous solution of 0.09 mol/L sodium sulfide to the alkaline precursor solution obtained in
步骤4,将步骤3获得的含有碱性前驱体与硫化钠的混合水溶液转移置高压釜中加热至60℃并恒温30min,再加热至110℃并恒温130min,冷却,再用过量的乙醇离心,获得沉淀,该沉淀为四元水溶性量子点(即:表面包覆剂包覆的AgInGaS量子点)。Step 4, transfer the mixed aqueous solution containing the alkaline precursor and sodium sulfide obtained in step 3 into an autoclave, heat to 60°C and hold at constant temperature for 30min, then heat to 110°C and hold at constant temperature for 130min, cool, and then centrifuge with excess ethanol, A precipitate was obtained, which was a quaternary water-soluble quantum dot (ie, AgInGaS quantum dot coated with a surface capping agent).
实施例4Example 4
一种四元水溶性量子点的制备方法,该方法通过如下步骤实现:A preparation method of quaternary water-soluble quantum dots, the method is realized by the following steps:
步骤1,分别将2.5ml 0.04mol/L的硝酸银水溶液、1.4mL 0.05mol/L的硝酸铟水溶液、10mL 0.02mol/L的氯化镓水溶液混合搅拌均匀,再加入1mL 0.4mol/L的Glu-Cys-Pro寡肽水溶液和4.5mL 2.7mol/L的柠檬酸钠水溶液混合形成的包覆剂水溶液并搅拌均匀,获得前驱体溶液;Step 1, respectively mix and stir 2.5ml 0.04mol/L silver nitrate aqueous solution, 1.4mL 0.05mol/L indium nitrate aqueous solution, and 10mL 0.02mol/L gallium chloride aqueous solution, and then add 1mL 0.4mol/L Glu -The coating agent aqueous solution formed by mixing the Cys-Pro oligopeptide aqueous solution and the 4.5 mL 2.7 mol/L sodium citrate aqueous solution and stirring evenly to obtain the precursor solution;
步骤2,向所述步骤1获得的前驱体溶液中加入浓度为1mol/mL的氢氧化钠调节pH值至9,获得碱性前驱体溶液;
步骤3,向所述步骤2获得的碱性前驱体溶液中加入10.1mL 0.11mol/L的硫代乙酰胺的水溶液搅拌均匀,获得含有碱性前驱体与硫代乙酰胺的混合水溶液;Step 3, adding 10.1 mL of an aqueous solution of 0.11 mol/L thioacetamide to the alkaline precursor solution obtained in
步骤4,将步骤3获得的含有碱性前驱体与硫代乙酰胺的混合水溶液转移置高压釜中加热至60℃并恒温30min,再加热至110℃并恒温130min,冷却,再用过量的乙醇离心,获得沉淀,该沉淀为四元水溶性量子点(即:表面包覆剂包覆的AgInGaS量子点)。Step 4, transfer the mixed aqueous solution containing the alkaline precursor and thioacetamide obtained in step 3 into an autoclave, heat to 60°C and keep the temperature constant for 30min, then heat to 110°C and keep the constant temperature for 130min, cool, and then use excess ethanol Centrifuge to obtain a precipitate, which is a quaternary water-soluble quantum dot (ie, AgInGaS quantum dot coated with a surface coating agent).
实施例5Example 5
一种四元水溶性量子点的制备方法,该方法通过如下步骤实现:A preparation method of quaternary water-soluble quantum dots, the method is realized by the following steps:
步骤1,分别将1ml 0.1mol/L的硝酸银水溶液、1.6mL 0.05mol/L的硝酸铟水溶液、15mL 0.02mol/L的硫酸镓水溶液混合搅拌均匀,再加入2mL 0.3mol/L的Glu-Cys-Pro寡肽水溶液和4.5mL 2.64mol/L的柠檬酸钠水溶液混合形成的包覆剂水溶液并搅拌均匀,获得前驱体溶液;Step 1, respectively mix and stir 1ml 0.1mol/L silver nitrate aqueous solution, 1.6mL 0.05mol/L indium nitrate aqueous solution, and 15mL 0.02mol/L gallium sulfate aqueous solution, and then add 2mL 0.3mol/L Glu-Cys -The coating agent aqueous solution formed by mixing the Pro oligopeptide aqueous solution and the 4.5 mL 2.64 mol/L sodium citrate aqueous solution and stirring evenly to obtain the precursor solution;
步骤2,向所述步骤1获得的前驱体溶液中加入浓度为1mol/mL的氢氧化钠调节pH值至9,获得碱性前驱体溶液;
步骤3,向所述步骤2获得的碱性前驱体溶液中加入9.6mL 0.15mol/L的硫代乙酰胺的水溶液搅拌均匀,获得含有碱性前驱体与硫代乙酰胺的混合水溶液;Step 3, adding 9.6 mL of an aqueous solution of 0.15 mol/L thioacetamide to the alkaline precursor solution obtained in
步骤4,将步骤3获得的含有碱性前驱体与硫代乙酰胺的混合水溶液转移置高压釜中加热至60℃并恒温30min,再加热至110℃并恒温130min,冷却,再用过量的乙醇离心,获得沉淀,该沉淀为四元水溶性量子点(即:表面包覆剂包覆的AgInGaS量子点)。Step 4, transfer the mixed aqueous solution containing the alkaline precursor and thioacetamide obtained in step 3 into an autoclave, heat to 60°C and keep the temperature constant for 30min, then heat to 110°C and keep the constant temperature for 130min, cool, and then use excess ethanol Centrifuge to obtain a precipitate, which is a quaternary water-soluble quantum dot (ie, AgInGaS quantum dot coated with a surface coating agent).
量子点的性能检测试实验:Quantum dot performance testing experiment:
采用高分辨透射电子显微镜对实施例1至实施例5获得的量子点的形貌进行观察,如图2所示,从图2中可以看到,量子点的尺寸在3nm左右;观察到的衍射条纹很清晰,说明产物的结晶质量非常高,缺陷极少。这使得本发明的量子点的荧光量子产率都很高,如下文所述。The morphology of the quantum dots obtained in Examples 1 to 5 was observed by high-resolution transmission electron microscopy, as shown in Figure 2. It can be seen from Figure 2 that the size of the quantum dots is about 3 nm; the observed diffraction The stripes are very clear, indicating that the crystalline quality of the product is very high and there are few defects. This results in high fluorescence quantum yields for the quantum dots of the present invention, as described below.
采用荧光光谱仪对实施例1至实施例5获得的量子点进行测定,测定结果如图3所示,从图3中可以看到,量子点的发光波长分别为525nm、545nm、562nm、573nm和605nm,这说明通过改变本发明的参数,可以得到发光波长不同的产物;此外观察到实施例1至实施例5获得的量子点的尺寸没有明显变化,这说明发光波长的改变不是由于尺寸的改变造成的,这是本发明的量子点与传统二元量子点的明显不同之处。The quantum dots obtained in Examples 1 to 5 were measured by a fluorescence spectrometer. The measurement results are shown in Figure 3. It can be seen from Figure 3 that the emission wavelengths of the quantum dots are 525 nm, 545 nm, 562 nm, 573 nm and 605 nm, respectively. , which shows that by changing the parameters of the present invention, products with different emission wavelengths can be obtained; in addition, it was observed that the size of the quantum dots obtained in Examples 1 to 5 did not change significantly, which indicates that the change in emission wavelength is not due to the change in size. Yes, this is the obvious difference between the quantum dots of the present invention and the traditional binary quantum dots.
对实施例1至实施例5获得的量子点的荧光量子产率进行检测,检测结果如图4所示,从图4中可以看到,量子产率分别为23%、26%、33%、28%和35%,均大于20%。The fluorescence quantum yields of the quantum dots obtained in Examples 1 to 5 were detected, and the detection results were shown in Figure 4. As can be seen from Figure 4, the quantum yields were 23%, 26%, 33%, 28% and 35%, both greater than 20%.
采用生命科学领域公知的方法对实施例1至实施例5获得的量子点进行细胞毒性检测,检测结果如图5所示,从图5中可以看到,所有合成的量子点对正常细胞孵化48小时后的存活率都在95%以上,毒性极小,对于生物领域而言,可以称其为无毒量子点。The quantum dots obtained in Examples 1 to 5 were tested for cytotoxicity using methods known in the field of life sciences. The test results are shown in Figure 5. It can be seen from Figure 5 that all the synthesized quantum dots were incubated for normal cells48 The survival rate after an hour is more than 95%, and the toxicity is extremely small. For the biological field, it can be called non-toxic quantum dots.
可见,利用本发明实施例获得的量子点具有良好的光学性质和生物相容性,在光电领域、生命科学领域以及医学领域均具有较好的应用前景。It can be seen that the quantum dots obtained by the embodiments of the present invention have good optical properties and biocompatibility, and have good application prospects in the fields of optoelectronics, life sciences and medicine.
以上所述,仅为本发明的较佳实施例而已,并非用于限定本发明的保护范围。The above descriptions are only preferred embodiments of the present invention, and are not intended to limit the protection scope of the present invention.
Claims (7)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810023802.2A CN108659814B (en) | 2018-01-10 | 2018-01-10 | Quaternary water-soluble quantum dot and preparation method and application thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810023802.2A CN108659814B (en) | 2018-01-10 | 2018-01-10 | Quaternary water-soluble quantum dot and preparation method and application thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN108659814A CN108659814A (en) | 2018-10-16 |
| CN108659814B true CN108659814B (en) | 2020-08-14 |
Family
ID=63784810
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201810023802.2A Active CN108659814B (en) | 2018-01-10 | 2018-01-10 | Quaternary water-soluble quantum dot and preparation method and application thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN108659814B (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110407247B (en) * | 2019-07-31 | 2022-04-01 | 上海电力大学 | Red water-soluble indium sulfide silver quantum dot and one-step synthesis method and application thereof |
| CN120209828A (en) * | 2019-08-23 | 2025-06-27 | 凸版印刷株式会社 | Quantum dots and methods for making the same |
| CN115244154B (en) * | 2020-03-09 | 2023-12-19 | 国立大学法人东海国立大学机构 | Method for producing semiconductor nanoparticles |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101665550B1 (en) * | 2015-08-24 | 2016-10-12 | 홍익대학교 산학협력단 | I-III-VI white light emitting quantum dots and method for producing the same |
| KR101734465B1 (en) * | 2016-03-30 | 2017-05-11 | 홍익대학교 산학협력단 | White electroluminescent lighting device based on a single quantum dot emitter and method for fabricating the same |
| KR101734464B1 (en) * | 2016-02-02 | 2017-05-11 | 홍익대학교 산학협력단 | Mn I--VI Mn-doped I--VI type white light-emitting quantum dots for white light-emitting diode method for synthesizing the same and white light-emitting diode using the same |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3329516B1 (en) * | 2015-07-30 | 2020-09-30 | OSRAM Opto Semiconductors GmbH | Low cadmium nanocrystalline quantum dot heterostructure |
-
2018
- 2018-01-10 CN CN201810023802.2A patent/CN108659814B/en active Active
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101665550B1 (en) * | 2015-08-24 | 2016-10-12 | 홍익대학교 산학협력단 | I-III-VI white light emitting quantum dots and method for producing the same |
| KR101734464B1 (en) * | 2016-02-02 | 2017-05-11 | 홍익대학교 산학협력단 | Mn I--VI Mn-doped I--VI type white light-emitting quantum dots for white light-emitting diode method for synthesizing the same and white light-emitting diode using the same |
| KR101734465B1 (en) * | 2016-03-30 | 2017-05-11 | 홍익대학교 산학협력단 | White electroluminescent lighting device based on a single quantum dot emitter and method for fabricating the same |
Non-Patent Citations (1)
| Title |
|---|
| Synthesis of New Fluorescent Semiconductor Nanoparticles and Their Optical Uses;Susumu Kuwabata et al,;《ECS Transactions》;20121231;第45卷(第5期);第131-137页 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN108659814A (en) | 2018-10-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN107629783B (en) | Core-shell quantum dot, preparation method and application thereof | |
| CN107681054B (en) | Preparation method of perovskite crystal nanowire | |
| JP4567436B2 (en) | Luminescent nanoparticles and methods for their preparation | |
| CN102517003B (en) | Hydro-thermal preparation method for novel near infrared water-soluble copper-indium-sulfur three-element quantum dots | |
| JP5371011B2 (en) | Novel nanoparticle emitter | |
| CN108659814B (en) | Quaternary water-soluble quantum dot and preparation method and application thereof | |
| TW201835296A (en) | Semiconducting light emitting nanoparticle | |
| CN109312489A (en) | Method for synthesizing core-shell nanocrystals at high temperature | |
| Wang et al. | Multinary copper-based chalcogenide semiconductor nanocrystals: synthesis and applications in light-emitting diodes and bioimaging | |
| JP2009527437A (en) | Synthesis of alloy nanocrystals in aqueous or water-soluble solvents | |
| CN107758638B (en) | A kind of preparation method that water soluble hydroxy apatite fluorescent is nanocrystalline | |
| CN107815309A (en) | A kind of preparation method of water soluble fluorescence fluorination calcium nano | |
| CN109233809B (en) | Preparation of composite bifunctional perovskite material combining thermoluminescence and photoluminescence performance | |
| CN105018069B (en) | A kind of nuclear shell structure quantum point and its aqueous phase preparation method with long fluorescence lifetime | |
| US8937373B2 (en) | Highly luminescent II-V semiconductor nanocrystals | |
| JP2008534424A (en) | CDTE / GSH core-shell quantum dots | |
| Fu et al. | Aqueous synthesis and fluorescence-imaging application of CdTe/ZnSe core/shell quantum dots with high stability and low cytotoxicity | |
| CN110846025A (en) | A method for improving the fluorescence quantum yield of Ⅱ-Ⅵ quantum dots | |
| CN105018068B (en) | A kind of fluorescence-encoded micro-beads based on long-life composite quantum dot and preparation method thereof | |
| TWI553174B (en) | Preparation of Quantum Dot Fiber | |
| CN116622373B (en) | Efficient green fluorescent Bi2S3Quantum dot and preparation method thereof | |
| CN105950135B (en) | Quantum dot, the preparation method and use of nucleocapsid | |
| JP2021517548A (en) | Quantum dot manufacturing method | |
| CN104263362B (en) | A kind of Ag-In-Zn-S quad alloy nanometer rod and preparation method thereof | |
| KR101923431B1 (en) | Method for manufacturing single crystalline CdTe nanowire by self assembly under light |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |